Henrik Kjaer Hansen

Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway.

Sonion A/S design and manufactures micro-acoustic and micro-mechanical components for hearing instruments, in-ear earphones and earphones. The firm offers products such as receivers, microphones, noise cancelling microphone, boom microphones, vibration sensors, active telecoils, passive telecoils, bone conduction vibrator, volume controls, switches, connector systems, trimmers, faceplates, tapers, and socketm, combination units and sonion sound dampers. The company was founded by Jorgen Weber Jensen and Jens-Jorn Stockholm in 1974 and is headquartered in Roskilde, Denmark.

Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark.

Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The private company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010.

Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets.

WCG Clinical, Inc. provides clinical trial solutions, which focus on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance. It transformational solutions enable biopharmaceutical companies, contract research organizations, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human protection. The company was founded in 2012 and is headquartered in Princeton, NJ.